HAWTHORNE, N.Y.--(BUSINESS WIRE)--April 20, 2006--Taro Pharmaceutical Industries Ltd. (NASDAQ: TARO - News) today announced that the Company will report its financial results for the fourth quarter and full year 2005 following the completion of additional work by its independent auditing firm, Kost Forer Gabbay & Kasierer, a Member of Ernst & Young Global. The additional work being done by the auditors relates to the process of estimating accounts receivable reserves.
